Condition
COVID-19, Long Haul
Total Trials
3
Recruiting
3
Active
3
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 2 (1)
P 4 (1)
Trial Status
Recruiting3
Clinical Trials (3)
Showing 3 of 3 trials
NCT06441955Phase 4RecruitingPrimary
Covid-19 Long Haul Preventative and Health Promotion Care Clinical Trial Acceleration Program.
NCT06391970Not ApplicableRecruitingPrimary
Digital Cognition Study During Long-COVID
NCT05967052Phase 2Recruiting
Investigation of Treating Chronic Fatigue Syndrome After COVID With Pharmacotherapy (Pregabalin) or Complex Rehabilitation
Showing all 3 trials